FDA: Long-Term Plavix Use Doesn’t Increase Death Risk

(November 9, 2015, 1:47 PM EST) -- SILVER SPRING, Md. — Long-term use of the anticoagulant drug Plavix (clopidogrel) does not increase or decrease the overall risk of death in patients with or at risk for heart disease, the Food and Drug Administration announced Nov. 6 in a drug safety communication....

Related Sections